Diebold Nixdorf, Incorporated
| Security | DBD / Diebold Nixdorf, Incorporated |
| Insider | Jonathan Myers |
This page shows the track record and history of Myers Jonathan
insider trades in Diebold Nixdorf, Incorporated. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.
It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean
it is illegal for them to make any
trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Jonathan Myers in DBD / Diebold Nixdorf, Incorporated. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Max |
Price at Max |
Max Profit ($) |
Max Return (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Jonathan Myers in DBD / Diebold Nixdorf, Incorporated. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Min |
Price at Min |
Max Loss Avoided ($) |
Max Loss Avoided (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Transaction History
| File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-03 | 2025-03-01 | 4 | Myers Jonathan | DBD | Common Stock | D | 44.2300 | -1,586 | -70 | 38,770 | ||||
| 2025-03-03 | 2025-03-01 | 4 | Myers Jonathan | DBD | Common Stock | D | 13,137 | 40,356 | ||||||
| 2025-01-22 | 2025-01-19 | 4 | Myers Jonathan | DBD | Common Stock | D | 44.4900 | -1,101 | -49 | 27,219 | ||||
| 2024-03-05 | 2024-03-01 | 4 | Myers Jonathan | DBD | Common Stock | D | 15,798 | 28,320 | ||||||
| 2024-01-23 | 2024-01-19 | 4 | Myers Jonathan | DBD | Common Stock | D | 12,522 | 12,522 | ||||||
| 2023-08-11 | 2023-08-11 | 4 | Myers Jonathan By Minor Child | DBD | Common Shares | I | -200 | 0 | ||||||
| 2023-08-11 | 2023-08-11 | 4 | Myers Jonathan | DBD | Common Shares | D | -107,804 | 0 | ||||||
| 2023-02-03 | 2023-01-31 | 4 | Myers Jonathan | DBD | Common Shares | D | 2.3900 | -19,100 | -46 | 107,804 | ||||
| 2022-08-29 | 2022-08-22 | 4 | Myers Jonathan | DBD | Common Shares | D | 126,904 | 126,904 | ||||||
| 2022-08-29 | 3 | Myers Jonathan By Minor Child | DBD | Common Shares | I | 200 |
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)
